ورود
مقالات فارسیISIکنفرانسهاژورنالها

مقالات مجله بین المللی سیاست و مدیریت بهداشت، دوره 12، شماره 0

1.Modelling the Health Policy Process: One Size Fits All or Horses for Courses? FullText
2.International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (۲۰۱۳-۲۰۲۳) FullText
3.Reducing the Risks of Nuclear War—The Role of Health Professionals
4.Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency
5.An Overview of Stakeholders, Methods, Topics, and Challenges in Participatory Approaches Used in the Development of Medical Devices: A Scoping Review FullText
6.Re-evaluating Our Knowledge of Health System Resilience During COVID-۱۹: Lessons From the First Two Years of the Pandemic FullText
7.How International Health System Austerity Responses to the ۲۰۰۸ Financial Crisis Impacted Health System and Workforce Resilience – A Realist Review FullText
8.Barriers and Facilitators to Implementing Interventions for Reducing Avoidable Hospital Readmission: Systematic Review of Qualitative Studies FullText
9.Systems Thinking and Complexity Science Methods and the Policy Process in Non-communicable Disease Prevention: A Systematic Scoping Review FullText
10.Towards A Framework for Implementing Remote Patient Monitoring From an Integrated Care Perspective: A Scoping Review FullText
11.Model Choice for Quantitative Health Impact Assessment and Modelling: An Expert Consultation and Narrative Literature Review FullText
12.National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis FullText
13.Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review FullText
14.Reflections on Managing the Performance of Value-Based Healthcare: A Scoping Review FullText
15.A Review of the Applicability of Current Green Practices in Healthcare Facilities FullText
16.Developing a Conceptual Framework for an Age-Friendly Health System: A Scoping Review FullText
17.Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review FullText
18.Human Resources for Health in Conflict Affected Settings: A Scoping Review of Primary Peer Reviewed Publications ۲۰۱۶–۲۰۲۲ FullText
19.Economic Sanctions Affecting Household Food and Nutrition Security and Policies to Cope With Them: A Systematic Review FullText
20.Characteristics of Medical Deserts and Approaches to Mitigate Their Health Workforce Issues: A Scoping Review of Empirical Studies in Western Countries FullText
21.Interactions Between Nutrition Professionals and Industry: A Scoping Review FullText
22.Taking on the Corporate Determinants of Ill-health and Health Inequity: A Scoping Review of Actions to Address Excessive Corporate Power to Protect and Promote the Public’s Health FullText
23.Benchmarking Drug Regulatory Systems for Capacity Building: An Integrative Review of Tools, Practice, and Recommendations FullText
24.The Experiences of Strategic Purchasing of Healthcare in Nine Middle-Income Countries: A Systematic Qualitative Review FullText
25.What Are Healthy Societies? A Thematic Analysis of Relevant Conceptual Frameworks FullText
26.How to Build Healthy Societies: A Thematic Analysis of Relevant Conceptual Frameworks FullText
27.Scoping Review of International Experience of a Dedicated Fund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand FullText
28.Barriers and Opportunities for WHO ‘Best Buys’ Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review FullText
29.Measuring Accessibility to Healthcare Using Taxi Trajectories Data: A Case Study of Acute Myocardial Infarction Cases in Beijing FullText
30.Let’s Talk About it: The Utility of Formalized Support for Medical Residents
31.Population Size Estimation of People Who Use Illicit Drugs and Alcohol in Iran (۲۰۱۵-۲۰۱۶) FullText
32.Impact of the COVID-۱۹ Pandemic on Elective and Emergency Inpatient Procedure Volumes in Switzerland – A Retrospective Study Based on Insurance Claims Data FullText
33.The Hospital of Tomorrow Case Study: Multidisciplinarity, Inclusiveness and Holistic Approaches to Foster Innovation in Complex Organizations FullText
34.A Comparative Analysis on the Social Determinants of COVID-۱۹ Vaccination Coverage in Fragile and Conflict Affected Settings and Non-fragile and Conflict Affected Settings FullText
35.Barriers Toward the National Program for Prevention and Control of Diabetes in Iran: A Qualitative Exploration FullText
36.Improving Insurance Protection for Rare Diseases: Economic Burden and Policy Effects — Simulation of People With Pompe Disease in China FullText
37.Non-communicable Disease-Related Sustainable Development Goals for ۶۶ Belt and Road Initiative Countries FullText
38.Explaining Variations in Long-term Care Use and Expenditures Under the Public Long-term Care Insurance Systems: A Case Study Comparison of Korea and Japan FullText
39.Re-aligning Incentives to Address Informal Payments in Tanzania Public Health Facilities: A Discrete Choice Experiment FullText
40.The Generative Mechanisms of Financial Strain and Financial Well-Being: A Critical Realist Analysis of Ideology and Difference FullText
41.Energy as a Social and Commercial Determinant of Health: A Qualitative Study of Australian Policy FullText
42.Understanding the Dynamics of More Restrictive Medicines Policy: A Case Study of Codeine Up-Scheduling in Australia FullText
43.To What Extent Do Free Healthcare Policies and Performance-Based Financing Reduce Out-of-Pocket Expenditures for Outpatient services? Evidence From a Quasi-experimental Study in Burkina Faso FullText
44.Realistic Evaluation of the Integrated Electronic Diagnosis Approach (IeDA) for the Management of Childhood Illnesses at Primary Health Facilities in Burkina Faso FullText
45.From Local Action to Global Policy: A Comparative Policy Content Analysis of National Policies to Address Musculoskeletal Health to Inform Global Policy Development FullText
46.Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands FullText
47.What Makes People With Chronic Illnesses Discontinue Treatment? A Practice Theory Informed Analysis of Adherence to Treatment among Patients With Drug-Resistant Tuberculosis in Pakistan FullText
48.Impact of COVID-۱۹ Containment Measures on Unemployment: A Multi-country Analysis Using a Difference-in-Differences Framework FullText
49.What Factors Explain Low Adoption of Digital Technologies for Health Financing in an Insurance Setting? Novel Evidence From a Quantitative Panel Study on IMIS in Tanzania FullText
50.The Maritime SPOR SUPPORT Unit (MSSU) Bridge Process: An Integrated Knowledge Translation Approach to Address Priority Health Issues and Increase Collaborative Research in Nova Scotia, Canada FullText
51.Political Prioritisation for Performance-Based Financing at the County Level in Kenya: ۲۰۱۵ to ۲۰۱۸ FullText
52.Toward Universal Health Coverage: Regional Inequalities and Potential Solutions for Alleviating Catastrophic Health Expenditure in the Post-poverty Elimination Era of China FullText
53.Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program FullText
54.Health Preparedness and Narrative Rationality: A Call for Narrative Preparedness FullText
55.What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward FullText
56.Experiences and Implications of the First Wave of the COVID-۱۹ Emergency in Italy: A Social Science Perspective FullText
57.Sustaining a New Model of Acute Stroke Care: A Mixed-Method Process Evaluation of the Melbourne Mobile Stroke Unit FullText
58.Institutional Variance in Mortality after Percutaneous Coronary Intervention for Acute Myocardial Infarction in Korea, Japan, and Taiwan FullText
59.Commercializing Personal Health Information: A Critical Qualitative Content Analysis of Documents Describing Proprietary Primary Care Databases in Canada FullText
60.Improving Performance in Complex Surroundings: A Mixed Methods Evaluation of Two Hospital Strategies in the Netherlands FullText
61.How Did Governments Address the Needs of People With Disabilities During the COVID-۱۹ Pandemic? An Analysis of ۱۴ Countries’ Policies Based on the UN Convention on the Rights of Persons With Disabilities FullText
62.Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-۱۹ Pandemic FullText
63.Power and Other Commercial Determinants of Health: An Empirical Study of the Australian Food, Alcohol, and Gambling Industries FullText
64.Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy FullText
65.The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study FullText
66.Factors Associated With In-Hospital Death Among Pneumonia Patients in US Hospitals From ۲۰۱۶~۲۰۱۹ FullText
67.Impact of Active Disinvestment on Decision-Making for Surgery in Patients With Subacromial Pain Syndrome: A Qualitative Semi-structured Interview Study Among Hospital Sales Managers and Orthopedic Surgeons FullText
68.Global Stillbirth Policy Review – Outcomes And Implications Ahead of the ۲۰۳۰ Sustainable Development Goal Agenda FullText
69.Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in ۲۰۱۷: A Cross-sectional Analysis FullText
70.Effects of the Long-term Care Insurance on Health Among Older Adults: A Panel Data From China FullText
71.Scaling-Up eConsult: Promising Strategies to Address Enabling Factors in Four Jurisdictions in Canada FullText
72.Impact of COVID-۱۹ on Utilisation of Funds by People With Disabilities: Lessons Drawn From the Australian National Disability Insurance Scheme FullText
73.Women Consumers’ Views on Legislation to Restrict Prominent Placement and Multibuy Promotions of High Fat, Sugar, and Salt Products in England: A Qualitative Perspective FullText
74.Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands FullText
75.Using System Dynamics to Understand Transnational Corporate Power in Diet-Related Non-communicable Disease Prevention Policy-Making: A Case Study of South Africa FullText
76.Impact of China’s National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin FullText
77.The Macroeconomic Impact of Increasing Investments in Malaria Control in ۲۶ High Malaria Burden Countries: An Application of the Updated EPIC Model FullText
78.Examining the Long-term Spillover Effects of a Pay-forPerformance Program in a Healthcare System That Lacks Referral Arrangements FullText
79.How the Stringency of the COVID-۱۹ Restrictions Influences Motivation for Adherence and Well-Being: The Critical Role of Proportionality FullText
80.Factors Associated With Emergency Department Visits Among Patients Receiving Publicly-Funded Homecare Services: A Retrospective Chart Review From Southern Taiwan Regional Hospital FullText
81.Implementation of Medicines Pricing Policies in Ghana: The Interplay of Policy Content, Actors’ Participation, and Context FullText
82.Adaptive Mechanisms of Health Zones to Chronic Traumatic Events in Eastern DRC: A Multiple Case Study FullText
83.Health System Considerations for Community-Based Implementation of Automated Respiratory Counters to Identify Childhood Pneumonia in ۵ Regions of Ethiopia: A Qualitative Study FullText
84.Effects of DementiaNet’s Community Care Network Approach on Admission Rates and Healthcare Costs: A Longitudinal Cohort Analysis FullText
85.Predictors of Mothers’ Care Seeking Behavior for Common Childhood Illnesses: Findings From the Afghanistan Health Survey ۲۰۱۵ FullText
86.Patients’ and Care Professionals’ Evaluation of the Effect of a Hospital Group on Integrated Care in Chinese Urban Health Systems: A Propensity Score Matching and Difference-in-Differences Regression Approach FullText
87.New Zealand Pae Ora Healthcare Reforms ۲۰۲۲: Viable by Design? A Qualitative Study Using the Viable System Model FullText
88.Delivery and Prioritization of Surgical Care in Canada During COVID-۱۹: An Environmental Scan FullText
89.Long-term Care Insurance and Health and Perceived Satisfaction of Older Chinese: Comparisons Between Urban/Rural Areas, Chronic Conditions, and Their Intersectionality FullText
90.The Effect of Integrated Care After Discharge From Hospitals on Outcomes Among Korean Older Adults FullText
91.Development of a Taxonomy of Policy Interventions for Integrating Nurse Practitioners into Health Systems FullText
92.Overcoming Political Fragmentation: The Potential of Meso-Level Mechanisms; Comment on “Integration or Fragmentation of Health Care? Examining Policies and Politics in a Belgian Case Study”
93.Belgium’s Healthcare System: The Way Forward to Address the Challenges of the ۲۱st Century; Comment on “Integration or Fragmentation of Health Care? Examining Policies and Politics in a Belgian Case Study”
94.Beyond “Lack of Political Will”: Elaborating Political Economy Concepts to Advance “Thinking and Working Politically”; Comment on “Health Coverage and Financial Protection in Uganda: A Political Economy Perspective”
95.What Might Be Required for Inspections to Be Considered Fair?; Comment on “What Lies Behind Successful Regulation? A Qualitative Evaluation of Pilot Implementation of Kenya’s Health Facility Inspection Reforms”
96.Policy by Pilot? Learning From Demonstration Projects for Integrated Care; Comment on “Integration or Fragmentation of Health Care? Examining Policies and Politics in a Belgian Case Study”
97.Impact of Regulatory Changes on Innovations in the Medical Device Industry; Comment on “Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We Ready for It? - A Viewpoint Paper”
98.How to Achieve Universal Health Coverage: A Case Study of Uganda Using the Political Process Model; Comment on “Health Coverage and Financial Protection in Uganda: A Political Economy Perspective”
99.Health Financing Reforms in Uganda: Dispelling the Fears and Misconceptions Related to Introduction of a National Health Insurance Scheme; Comment on “Health Coverage and Financial Protection in Uganda: A Political Economy Perspective”
100.Integration of Healthcare in Belgium: Insufficient, but There Is Hope; Comment on “Integration or Fragmentation of Health Care? Examining Policies and Politics in a Belgian Case Study”
101.Reinforcing Science and Policy, With Suggestions for Future Research; Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”
102.Integration of Chronic Care in a Fragmented Healthcare System; Comment on “Integration or Fragmentation of Health Care? Examining Policies and Politics in a Belgian Case Study”
103.Linking Costs and Quality in Healthcare: Towards Sustainable Healthcare Systems; Comment on “Hospitals Bending the Cost Curve With Increased Quality: A Scoping Review Into Integrated Hospital Strategies”
104.Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making; Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”
105.Neurotrauma Registries in Low- and Middle-Income Countries for Building Organized Neurotrauma Care: The LATINO Registry Experience; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”
106.Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design; Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”
107.COVID-۱۹ Aftermath: Direction Towards Universal Health Coverage in Low-Income Countries; Comment on “Health Coverage and Financial Protection in Uganda: A Political Economy Perspective”
108.The Challenges of Regulating Artificial Intelligence in Healthcare; Comment on “Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We Ready for It? - A Viewpoint Paper”
109.Systemic Reflections on Knowledge Transfer; Comment on “Sustaining Knowledge Translation Practices: A Critical Interpretive Synthesis”
110.Health System Shock Frameworks Between Theory, Application, and Assessment; Comment on “The COVID-۱۹ System Shock Framework: Capturing Health System Innovation During the COVID-۱۹ Pandemic”
111.Ways to Improve Hospital Quality - A Health System Perspective; Comment on “Hospitals Bending the Cost Curve With Increased Quality: A Scoping Review Into Integrated Hospital Strategies”
112.Health System Decentralization: Creating as Many Problems Than It Solves?; Comment on “The Effects of Health Sector Fiscal Decentralisation on Availability, Accessibility, and Utilisation of Healthcare Services: A Panel Data Analysis”
113.Vaccines, Politics and Mandates: Can We See the Forest for the Trees?; Comment on “Convergence on Coercion: Functional and Political Pressures as Drivers of Global Childhood Vaccine Mandates”
114.Complexities of Simultaneously Improving Quality and Lowering Costs in Hospitals; Comment on “Hospitals Bending the Cost Curve With Increased Quality: A Scoping Review Into Integrated Hospital Strategies”
115.Closing the Implementation Gap; Comment on “Insights Gained From a Re-analysis of Five Improvement Cases in Healthcare Integrating System Dynamics Into Action Research”
116.Additional Marketing Responses to a Tax on Sugar-Sweetened Beverages; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
117.The Role of the Policy Process on Health Service Reconfigurations: Evidence, Path Dependency and Framing; Comment on “‘Attending to History’ in Major System Change in Healthcare in England: Specialist Cancer Surgery Service Reconfiguration”
118.Framing Marketing Responses to National Regulation: The Four Ps in Transnational Corporate Political Discourse; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
119.Closing the Evidence Gap of Cash Transfer for Tuberculosis-Affected Households; Comment on “Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? – A Mixed-Methods Study on the Need for a Review of the Cash Transfer Policy in India”
120.A Pragmatic and Systemic Approach to Advance Research in Health Policy and Management; Comment on “Insights Gained From a Re-analysis of Five Improvement Cases in Healthcare Integrating System Dynamics Into Action Research”
121.Modelling a System to Help Improve It; Comment on “Insights Gained From a Re-analysis of Five Improvement Cases in Healthcare Integrating System Dynamics Into Action Research”
122.Companies’ Responses to a Tax on Sugar-Sweetened Beverages: Implications for Research; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
123.“Attending to Collaboration” in Major System Change in Healthcare in England: A Response; Comment on “‘Attending to History’ in Major System Change in Healthcare in England: Specialist Cancer Surgery Service Reconfiguration”
124.Global Neurotrauma Surveillance: Are National Databases Overrated?; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”
125.Institutionalisation Is a Vital Element for Fairness of Priority Setting in the Package Design if the Target is Universal Health Coverage; Comment on “Evidence-Informed Deliberative Processes for Health Benefits Package Design – Part II: A Practical Guide”
126.A New Perspective on Emerging Knowledge Translation Practices; Comment on “Sustaining Knowledge Translation Practices: A Critical Interpretive Synthesis”
127.The Geopolitics of Health Science Research; Comment on “The Roles of Regional Organisations in Strengthening Health Research Systems in Africa: Activities, Gaps, and Future Perspectives”
128.Austerity by Design; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
129.Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design; Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”
130.Vaccine Mandates in the COVID-۱۹ Era: Changing Paradigm or Public Health Opportunity?; Comment on “Convergence on Coercion: Functional and Political Pressures as Drivers of Global Childhood Vaccine Mandates”
131.Making Sense of the Complexity of Decentralised Governance; Comment on “The Effects of Health Sector Fiscal Decentralisation on Availability, Accessibility, and Utilisation of Healthcare Services: A Panel Data Analysis”
132.In Centralized Health Systems, Much Is Left Out When Analyses of Local HiAP Strategies Are Limited to Public Administration; Comment on “A Realist Explanatory Case Study Investigating How Common Goals, Leadership, and Committed Staff Facilitate Health in All Policies Implementation in the Municipality of Kuopio, Finland”
133.Pandemic’s Experience Questioning Capitalistic Dominance; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
134.Medical Dominance in Global Health Institutions as an Obstacle to Equity and Effectiveness; Comment on “Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process”
135.Beyond Received Wisdom and Authorised Accounts: What Knowledge Is Needed to Avoid Repeating History?; Comment on “‘Attending to History’ in Major System Change in Healthcare in England: Specialist Cancer Surgery Service Reconfiguration”
136.Things That Become Visible, for a While, Can Leave a Residue; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
137.Conditional Cash Transfer to Improve TB Outcomes: Necessary but Not Sufficient; Comment on “Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? – A Mixed-Methods Study on the Need for a Review of the Cash Transfer Policy in India”
138.Retrospective Impact Evaluation Continuing to Prove Challenging Irrespective of Setting: A Study of Research Impact Enablers and Challenges Cloaked as an Impact Evaluation?; Comment on “‘We’re Not Providing the Best Care If We Are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service”
139.Towards Improved Organizational Governance of Neurotrauma Surveillance; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”
140.Corporate Harm Minimisation: Promises and Perils; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
141.Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence; Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”
142.Unpacking Contexting and Institutionalizing as Complex Sustaining Practices; Comment on “Sustaining Knowledge Translation Practices: A Critical Interpretive Synthesis”
143.A Historical Legacy for Universal Health Coverage in the Republic of Korea: Moving Towards Health Coverage and Financial Protection in Uganda; Comment on “Health Coverage and Financial Protection in Uganda: A Political Economy Perspective” FullText
144.Health System Resilience as the Basis for Explanation Versus Evaluation; Comment on “The COVID-۱۹ System Shock Framework: Capturing Health System Innovation During the COVID-۱۹ Pandemic”
145.Post-pandemic Economics and Health Equity; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
146.Policy vs Business: Well-Designed Health-Related Food Policy Should Not Let Industry Marketing Undermine its Intended Effects; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
147.The Role of Registries in Neurotrauma Research: Translating Data Into Health Policy That Enhances Patient Care; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”
148.Comparative Politics, Political Settlements, and the Political Economy of Health Financing Reform; Comment on “Health Coverage and Financial Protection in Uganda: A Political Economy Perspective”
149.The Evolution of External Healthcare Regulation in England; From Performance Oversight to Supporting Improvement; Comment on “The Special Measures for Quality and Challenged Provider Regimes in the English NHS: A Rapid Evaluation of a National Improvement Initiative for Failing Healthcare Organisations”
150.The Instrumental Role of Strategic Communication to Counter Industry Marketing Responses to Sugary Drink Taxes; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
151.Regulatory Reforms for Health Facilities: Can These Suffice?; Comment on “What Lies Behind Successful Regulation? A Qualitative Evaluation of Pilot Implementation of Kenya’s Health Facility Inspection Reforms”
152.Evaluating Social Protection Policies With an Implementation Science Framework: India’s Direct Benefit Transfer for Tuberculosis; Comment on “Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? – A Mixed-Methods Study on the Need for a Review of the Cash Transfer Policy in India”
153.Contextual Factors That May Impact on the Development and Implementation of the Sugary Drinks Policy; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
154.The Fentanyl System Shock – Are There Lessons to Learn From the COVID-۱۹ System Shock Framework?; Comment on “The COVID-۱۹ System Shock Framework: Capturing Health System Innovation During the COVID-۱۹ Pandemic”
155.A Gateway Framework to Guide Major Health System Changes; Comment on “‘Attending to History’ in Major System Change in Healthcare in England: Specialist Cancer Surgery Service Reconfiguration”
156.Knowledge Translation as Cultural and Epistemic Translation; Comment on “Sustaining Knowledge Translation Practices: A Critical Interpretative Synthesis”
157.Routinizing the Use of Evidence in Policy – What is Needed?; Comment on “Sustaining Knowledge Translation Practices: A Critical Interpretive Synthesis”
158.Where Is Equity in HiAP?; Comment on “A Realist Explanatory Case Study Investigating How Common Goals, Leadership, and Committed Staff Facilitate Health in All Policies Implementation in the Municipality of Kuopio, Finland”
159.The Key Role of Social Movements in Protecting the Health of People and the Planet; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
160.Enhancing Multiple Ways of Knowing; Comment on “Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study”
161.Challenges and Strategic Solutions to Guarantee Last Mile Reach for an Indian TB Patient’s Nikshay Poshan Yojana; A Conditional Cash Transfer Scheme; Comment on “Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? – A Mixed-Methods Study on the Need for a Review of the Cash Transfer Policy in India”
162.Interest Groups and Health Facility Regulation – Future Directions for Health Policy and Systems Research; Comment on “What Lies Behind Successful Regulation? A Qualitative Evaluation of Pilot Implementation of Kenya’s Health Facility Inspection Reforms”
163.Translating, Contexting, and Institutionalising Knowledge Translation Practices in Northern Australia: Some Reflections; Comment on “Sustaining Knowledge Translation Practices: A Critical Interpretive Synthesis”
164.National Trauma Registries in LMICs: Long-Overdue Priority; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”
165.Bibliometrics, the “Clinical Diagnostics” of Research Impact; Comment on “‘We’re Not Providing the Best Care If We Are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service”
166.National Neurotrauma Registry Data in Low- and Middle-Income Countries – Current Status and Future Requirements; Comment on “Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries”
167.Coloniality, Elite Networks and Intersectionality: Key Concepts in Understanding Biomedical Power and Equity in Health Policy Processes; Comment on “Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process”
168.“Post”-pandemic Capitalism: Reform or Transform?; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
169.The Dynamics of Power Flow From the Global Health Financing; Comment on “Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process”
170.The Performance of Primary Healthcare in China: The Need for a Systematic Design for Improvement; Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China”
171.How to Account for Asymmetries in Deliberative Dialogues; Comment on “Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study”
172.Integrating System Dynamics and Action Research: Towards a Consideration of Normative Complexity; Comment on “Insights Gained From a Re-analysis of Five Improvement Cases in Healthcare Integrating System Dynamics Into Action Research”
173.For Sake of Youth and for Sake of Policies and Programmes. Why Youth Participation is a Right, a Requirement and a Value; Comment on “Between Rhetoric and Reality: Learnings From Youth Participation in the Adolescent and Youth Health Policy in South Africa”
174.Should We Worry About Spillover Effects of Sugar Sweetened Beverage Taxation Policies?; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
175.Cutting Edge Research? Realistic Expectations of Priorities, Scope and Engagement; Comment on “‘We’re Not Providing the Best Care If We Are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service”
176.Coercion and Its Discontents: The Promise and Peril of Increasingly Restrictive of Vaccination Mandates; Comment on “Convergence on Coercion: Functional and Political Pressures as Drivers of Global Childhood Vaccine Mandates”
177.Is It Time to Explore the Health Policy Process Within Governance and Health Systems Frameworks?; Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses?”
178.If Providing Best Care Means Being at the Cutting Edge of Research, Should It Be Implemented System-wide?; Comment on “‘We’re Not Providing the Best Care If We Are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service”
179.Challenges in Assessment of Health Systems Decentralization: The Role of Path Dependence and Choice of Indicators; Comment on “The Effects of Health Sector Fiscal Decentralisation on Availability, Accessibility, and Utilisation of Healthcare Services: A Panel Data Analysis”
180.Marketing Responses to the Taxation of Soft Drinks; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, ۲۰۱۹”
181.Using a Stages Model to Reveal the Politics in the Health Policy Process; Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses?”
182.A Social, Not a Natural Science: Engaging With Broader Fields in Health Policy Analysis; Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses?”
183.The Importance of Mapping Determinants, Attitudes and Beliefs of Vaccine Hesitancy in the Great Challenge of Compulsory Childhood Vaccination; Comment on “Convergence on Coercion: Functional and Political Pressures as Drivers of Global Childhood Vaccine Mandates”
184.Why Is It So Hard to Evaluate Knowledge Exchange?; Comment on “Sustaining Knowledge Translation Practices: A Critical Interpretive Synthesis”
185.Situating Biomedical and Professional Monopoly at the Intersections of Structural, Ideational and Agentic Power; Comment on “Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process”
186.Impact of the Regulatory Framework on Medical Device Software Manufacturers: Are the Guidance Documents Supporting the Practical Implementation?; Comment on “Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We Ready for It? – A Viewpoint Paper”
187.Health Science Research at a Regional Level: Insights From South America; Comment on “The Roles of Regional Organisations in Strengthening Health Research Systems in Africa: Activities, Gaps, and Future Perspectives”
188.Ensuring Global Health Equity in a Post-Pandemic Economy: Words Count!; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
189.Why Should Health Researchers Use Policy Theories?; Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses?”
190.Integrated Care Policies and Politics in Belgium: Conceptual, Contextual and Governance Linkages for More Effective Integrated Care Policy Management; Comment on “Integration or Fragmentation of Health Care? Examining Policies and Politics in a Belgian Case Study”
191.Embedded Research: Possibilities for Learning Health Systems; Comment on “‘We’re Not Providing the Best Care if We are Not on the Cutting Edge of Research’: A Research Impact Evaluation at a Regional Australian Hospital and Health Service”
192.Health Policy Analysis Requires Attending to Institutions; Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses?”
193.Advancing Youth Participation to Inform Equitable Health Policy; Comment on “Between Rhetoric and Reality: Learnings From Youth Participation in the Adolescent and Youth Health Policy in South Africa”
194.Rethinking Performance Measurement of Primary Care in China; Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China”
195.The Values of the Care Economy; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
196.Health in All Policies at the Local Level: What Facilitates Success?; Comment on “A Realist Explanatory Case Study Investigating How Common Goals, Leadership, and Committed Staff Facilitate Health in All Policies Implementation in the Municipality of Kuopio, Finland”
197.The Pervasiveness of Power: Dilemmas for Researchers of Major System Change in Healthcare; Comment on “‘Attending to History’ in Major System Change in Healthcare in England: Specialist Cancer Surgery Service Reconfiguration”
198.Advancing Empirics and Theory for a Deeper Political Economy Analysis; Comment on “Health Coverage and Financial Protection in Uganda: A Political Economy Perspective”
199.Policy Makes Politics; Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses?”
200.Beyond Policy: Strengthening District Level Access to Surgery Is Critical to Achieving Surgical Equity in Universal Health Coverage; Comment on “Improving Access to Surgery Through Surgical Team Mentoring – Policy Lessons From Group Model Building With Local Stakeholders in Malawi”
201.Quality Measurement as a Path to High Quality Care; Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China” FullText
202.Widening the Lens: Reflecting on the Mixing of System Dynamics With Action Research Alongside Work Within the Problem Structuring Methods Field; Comment on “Insights Gained From a Re-analysis of Five Improvement Cases in Healthcare Integrating System Dynamics Into Action Research”
203.Frustrations of a Longtime Global Issues Activist; Comment on “Ensuring Global Health Equity in a Post-pandemic Economy”
204.Harnessing Country Experiences for Health Benefit Package Design: Evidence-Informed Deliberative Processes and Experiences From the Joint Learning Network; Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”
205.Integrating System Dynamics Into Action Research: Drivers and Challenges in a Synergetic Complementarity; Comment on “Insights Gained From a Re-analysis of Five Improvement Cases in Healthcare Integrating System Dynamics Into Action Research”
206.Supporting Youth Participation in Health and Climate Justice Through Advocacy Training; Comment on “Between Rhetoric and Reality: Learnings From Youth Participation in the Adolescent and Youth Health Policy in South Africa”
207.Doing Health Policy Analysis: The Enduring Relevance of Simple Models; Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses”
208.Stakeholders’ Perceived Barriers and Successes of Quality Improvement Programs for Patients With Diabetes; Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China”
209.Investigating Resilience in Healthcare: Easier Said Than Done? A Response to the Recent Commentaries
210.Evidence-Informed Policy-Making: Will It Ever Be Enough? A Response to the Recent Commentary
211.Dual Agency: A Fresh Perspective to Identify Dilemma Mitigation Strategies – A Response to the Recent Commentaries
212.The Tale of Nine Belgian Health Ministers and a Multi-level Fragmented Governance System: Six Guiding Principles to Improve Integrated Care, Responsiveness, Resilience and Equity; A Response to the Recent Commentaries
213.Attributes and Features of Context Relevant to Knowledge Translation in Health Settings: A Response to Recent Commentaries
214.Challenges and Opportunities for Reducing Low-Value Care; A Response to Recent Commentaries
215.Universal and Targeted Policy for Health Equity in the Neoliberal Era; A Response to the Recent Commentaries
216.Political Economy and Research Silos: A Response to the Recent Commentaries
217.Advancing Social Protection and Tuberculosis Elimination in India – Beyond Cash Transfers and Towards Addressing Social and Structural Determinants for a Healthier Future; A Response to the Recent Commentaries
218.Bridging Borders for Health: The Vital Role of Regional Cooperation in Infectious Disease Control and Mitigation of Health Emergencies; A Response to the Recent Commentaries
219.The Dangers of Fiscal Decentralisation in Healthcare: A Response to the Recent Commentaries
220.Evolving Power Dynamics in Global Health: From Biomedical Hegemony to Market Dynamics in Global Health Financing; A Response to the Recent Commentaries
221.The Knowledge Translation Pizza-Dilemma: A Response to Recent Commentaries
222.Advancing Global Neurotrauma Surveillance Through National Registries: A Response to Recent Commentaries
223.Developing a Research Agenda for HiAP Implementation: A Response to the Recent Commentaries
224.Transforming Capitalism, From Top Down to Bottom Up; A Response to the Recent Commentaries
225.Measuring Research Impact in a Health Service Is a Worthy but Complex Goal; A Response to Recent Commentaries
226.How to Design Integrated Strategies to Improve Healthcare Quality Whilst Containing Healthcare Costs? A Response to the Recent Commentaries
227.Is Reformulation Still a Suitable Goal for Sugary Beverage Taxes? A Response to Recent Commentaries
228.Comparative Insights to Advance Political Economy Analysis: A Response to Recent Commentaries
229.Helping Healthcare to Help Itself: A Response to the Recent Commentaries
230.Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We There Yet? A Response to the Recent Commentaries
231.Evidence-Informed Surgical Systems Strengthening with Meaningful Stakeholder Involvement in Low-Resource Settings: A Response to Recent Commentaries
232.Zero-Covid Strategy: What’s Next? FullText
233.The Social Media Industry as a Commercial Determinant of Health
234.Development of Policy Recommendations to Support a National Autism Strategy: Case of a Virtual and Inclusive Stakeholder Engagement Process
235.Towards Legally Mandated Public Health Benchmarks
236.Ultra-Processed Food: The Tragedy of the Biological Commons
237.Implications of COVID-۱۹ for Public Health Theory and Praxis From a Complex Systems Perspective
238.Exploring the Establishment of Hospice Service System Integrating Medical Care and Funeral Services
239.Why Reducing Low-Value Care Fails to Bend the Cost Curve, and Why We Should Do it Anyway
240.Nurse Practitioner Integration: Insights Into the Next Generation of Policy and Research
241.Understanding the Wide-Reaching Impact of Healthcare Merger and Acquisition Activity
242.Do ChatGPT and Other Artificial Intelligence Bots Have Applications in Health Policy-Making? Opportunities and Threats FullText
243.Introducing Critical Accounting for Governance as a Tool in Exploring the Commercial Determinants of Health
244.Intersectoral Collaboration: What Works and What Doesn’t
245.Health and Care Workers in Pandemic Recovery: Major Challenges and Solutions
246.Using Financial Incentives and Market Mechanisms to Improve Hospitals’ Performance; A Double-edged Sword
247.Enhancing Priority-Setting Decision-Making Process Through Use of Intersectionality for Public Participation
248.Constructing Equitable Health Resilience: A Call for a Systems Approach to Intersectionality
249.Pricing New Drugs for COVID-۱۹ in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
250.Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence
251.Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases
تاریخ نمایه سازی مقالات: 17 مرداد 1403 - تعداد نمایش اطلاعات ژورنال: 89

آرشیو سال 1403 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1402 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1401 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1400 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1399 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1398 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1397 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1396 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1395 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1394 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1393 مجله بین المللی سیاست و مدیریت بهداشت

آرشیو سال 1392 مجله بین المللی سیاست و مدیریت بهداشت